Schedule 13G ownership disclosure

Bellerophon Therapeutics, Inc.

Security class unavailable

Event date: 2023-12-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-24-000074
Form type
SC 13G
Filer
Bellerophon Therapeutics, Inc.
CIK
CIK 1600132
Filed
Jan 26, 2024
Reporting period
Dec 18, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub